Literature DB >> 22840574

Outline of the report on cardiovascular disease in China, 2010.

Sheng Shou Hu1, Ling Zhi Kong, Run Lin Gao, Man Lu Zhu, Wen Wang, Yong Jun Wang, Zhao Su Wu, Wei Wei Chen, Ming Bo Liu.   

Abstract

Major and profound changes have taken place in China over the past 30 years. Rapid socioeconomic progress has exerted a great impact on lifestyle, ranging from food, clothing, working and living conditions, and means of transportation to leisure activities and entertainment. At the same time, new health problems have emerged, and health services are facing new challenges. Presently, cardiovascular diseases (CVD) are among the top health problems of the Chinese people, and pose a serious challenge to all engaged in the prevention and control of these diseases. An epidemic of CVD in China is emerging as a result of lifestyle changes, urbanization and longevity. Both national policy decision-making and medical practice urgently need an authoritative report which comprehensively reflects the trends in the epidemic of CVD and current preventive measures. Since 2005, guided by the Bureau of Disease Prevention of the Ministry of Health of the People's Republic of China and the National Center for Cardiovascular Diseases of China, nationwide experts in the fields of epidemiology, clinical medicine and health economics in the realms of CVD, cerebrovascular disease, diabetes and chronic kidney disease, completed the Report on Cardiovascular Diseases in China every year. The report aims to provide a timely review of the trend of the epidemic and to assess the progress of prevention and control of CVD. In addition, as the report is authoritative, representative and readable, it will become an information platform in the CVD field and an important reference book for government, academic institutes, medical organizations and clinical physicians. This publication is expected to play a positive role in the prevention and control of CVD in China. We present an abstract from the Report on Cardiovascular Diseases in China (2010), including trends in CVD, morbidity and mortality of major CVDs, up-to-date assessment of risk factors, as well as health resources for CVD, and a profile of medical expenditure, with the aim of providing evidence for decision-making in CVD prevention and control programs in China, and of delivering the most authoritative information on CVD prevention and control for all citizens. 2012 The Editorial Board of Biomedical and Environmental Sciences. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22840574     DOI: 10.3967/0895-3988.2012.03.001

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  77 in total

Review 1.  Global availability of cardiac rehabilitation.

Authors:  Karam Turk-Adawi; Nizal Sarrafzadegan; Sherry L Grace
Journal:  Nat Rev Cardiol       Date:  2014-07-15       Impact factor: 32.419

Review 2.  Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.

Authors:  Min-Seok Kim; Ju-Hee Lee; Eung Ju Kim; Dae-Gyun Park; Sung-Ji Park; Jin Joo Park; Mi-Seung Shin; Byung Su Yoo; Jong-Chan Youn; Sang Eun Lee; Sang Hyun Ihm; Se Yong Jang; Sang-Ho Jo; Jae Yeong Cho; Hyun-Jai Cho; Seonghoon Choi; Jin-Oh Choi; Seong Woo Han; Kyung Kuk Hwang; Eun Seok Jeon; Myeong-Chan Cho; Shung Chull Chae; Dong-Ju Choi
Journal:  Korean Circ J       Date:  2017-09-18       Impact factor: 3.243

3.  A Longitudinal Assessment of Parental Caregiving and Blood Pressure Trajectories: Findings from the China Health and Nutrition Survey for Women 2000-2011.

Authors:  Xiaoxiao Lu; Hee-Soon Juon; Xin He; Cher M Dallal; Ming Qi Wang; Sunmin Lee
Journal:  J Racial Ethn Health Disparities       Date:  2020-05-04

4.  Global Public Health Burden of Heart Failure.

Authors:  Gianluigi Savarese; Lars H Lund
Journal:  Card Fail Rev       Date:  2017-04

5.  Inhibited proliferation of human umbilical artery smooth muscle cells by xanthinol nicotinate.

Authors:  Xiaodan Bai; Lijun Huang; Kejie Hu; Fujun Qu
Journal:  Med Biol Eng Comput       Date:  2015-12-30       Impact factor: 2.602

Review 6.  Cardiovascular, diabetes, and cancer strips: evidences, mechanisms, and classifications.

Authors:  Chun-Song Hu; Qing-Hua Wu; Da-Yi Hu
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

7.  Chronic heart failure: opportunities for a bridge between China and the United States.

Authors:  Yingnan Bai; Piero Anversa; Junbo Ge
Journal:  Circ Res       Date:  2013-08-02       Impact factor: 17.367

8.  Pharmacokinetics, Safety and Tolerability of Sacubitril/Valsartan (LCZ696) After Single-Dose Administration in Healthy Chinese Subjects.

Authors:  Yi Han; Surya Ayalasomayajula; Wei Pan; Fan Yang; Yaozong Yuan; Thomas Langenickel; Markus Hinder; Sampath Kalluri; Parasar Pal; Gangadhar Sunkara
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

9.  Combined effects of hypertension and heart rate on the risk of stroke and coronary heart disease: a population-based prospective cohort study among Inner Mongolians in China.

Authors:  Chongke Zhong; Xiaoyan Zhong; Tian Xu; Hao Peng; Hongmei Li; Mingzhi Zhang; Aili Wang; Tan Xu; Yingxian Sun; Yonghong Zhang
Journal:  Hypertens Res       Date:  2015-08-20       Impact factor: 3.872

Review 10.  Clinical correlates and pharmacological management of Asian patients with concomitant diabetes mellitus and heart failure.

Authors:  Yvonne May Fen Chia; Tiew-Hwa Katherine Teng; Chanchal Chandramouli; Jonathan Yap; Michael MacDonald; Carolyn S P Lam
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.